Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

RB Pharmaceuticals Limited v. Biodelivery Sciences, No. 16-1044 (Fed. Cir. Aug. 10, 2016)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 16-1044
Decided
August 10, 2016
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit RB PHARMACEUTICALS LIMITED,

Appellant

v.

BIODELIVERY SCIENCES INTERNATIONAL, INC.,

Appellee

2016-1044

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2014-00325.

JUDGMENT

JEFFREY B. ELIKAN, Covington & Burling LLP, Washington, DC, argued for appellant. Also represented by JEFFREY HOWARD LERNER; DANIEL LADOW, JAMES M. BOLLINGER, MAGNUS ESSUNGER, Troutman Sanders LLP, New York, NY.

LEE CARL BROMBERG, McCarter & English, LLP, Boston, MA, argued for appellee. Also represented by DANIELLE L. HERRITT, ERIK PAUL BELT, KIA LYNN FREEMAN, WYLEY SAYRE PROCTOR.

2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT August 10, 2016 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

RB Pharmaceuticals Limited v. Biodelivery Sciences, No. 16-1044 (Fed. Cir. Aug. 10, 2016).

Record ID
CAFC-16-1044-20160810
Permalink
https://patentcasewatch.com/opinions/CAFC-16-1044-20160810

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.